custom image

Vaccinology in the Age of Pandemics:
Strategies Against COVID-19 & Other Global Threats

June 15–16, 2020 | 11:00AM–3:30PM ET | 3:00–7:30PM UTC | 5:00–9:30PM CEST*
*Program is subject to change


As the world faces the greatest global pandemic of our lifetimes, the critical importance of vaccine development has come to the forefront of scientific and public audiences alike. Over the course of history, vaccination has enabled us to conquer devastating diseases from measles to smallpox, but new challenges arise when addressing an emerging pandemic in real time. This virtual meeting will assemble the world’s leading vaccinology and global health experts to present the latest advances in vaccine design and development. Finally, this virtual conference will discuss how to best apply these strategies in the context of the current pandemic.

The field of vaccinology has made great leaps in recent years, providing novel technologies and approaches that can be leveraged to our advantage against the novel coronavirus, COVID-19. Incredible advances in science and technology now make it technically possible to develop vaccines against many new targets. Meanwhile, innovative approaches to vaccine development are tackling challenges of emerging infections and implementation in low-income countries. These advances, among many others, will guide the way towards a safe and effective COVID-19 vaccine. Additionally, these new scientific advances will set the stage for success against this pandemic, as vaccinologists race against the ever-rising global death toll.

This virtual meeting program will cover many important facets of vaccine science, technology and strategy, including:

  • transformative new technologies, including structure-based design, adjuvants, nucleic acid vaccines (especially RNA), viral vectors, systems biology, and controlled human infections
  • scientific underpinnings of new vaccinology strategies, including advances in the fields of human immunology, genomics, synthetic biology, molecular structure of antigens and antigen-antibody complexes, germinal centers, and microbiome
  • multidisciplinary technologies and strategies, including efforts of Coalition for Epidemic Preparedness Innovations (CEPI), Bill & Melinda Gates Foundation and Wellcome Trust, which will change the way vaccines are developed

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Regular Registration Rate: $50 USD

#VKSvaxcovid19

     



Scholarship Opportunities


Graduate students, postdoctoral fellows and early stage investigators, as well as life scientists from low- to middle- income countries (all career stages), are eligible to request a free registration code.


Learn More




Program Details



Keynote Speaker


Anthony S. Fauci, MD
Anthony S. Fauci, MD
NIAID, National Institutes of Health
Transforming Vaccinology: Considerations for the Next Decade



Editors Attending This Meeting


e67e325db8bba4b7931f567e1f0a935a.png1beba08dbf5604b540b56c94da3d97dd.png
Lakshmi Goyal, PhD, Cell Press
George Thomas, Frontiers
Speaking at this eSymposia

8052a45e547e38316b103d53ad3ebe88.png

Galit Alter

MIT and Harvard University

538e11be6af243466889e8176fafbe63.png

Yasmine Belkaid

NIAID, National Institutes of Health

Anthony S. Fauci, MD

Anthony S. Fauci

NIAID, National Institutes of Health

dbd1294e39aac1e9a2ad7971efcb70ed.png

George Fu Gao

Chinese Academy of Sciences


616baa7a2c9178f3dcc2d4c53f466fa8.png

Barney S. Graham

NIAID, National Institutes of Health


95ad987f1712aba161ce4389f1f31b74.png

Richard Hatchett

Coalition for Epidemic Preparedness Innovations, CEPI

2da2ebdbaef11040b08c5b1b9cd9d75b.png

Neil P. King

University of Washington

29c57b785ffcac2db9f67227c81e467c.png

Antonio Lanzavecchia

Institute for Research in Biomedicine

018753b23a68fa4b5d2042ef8b0d12b0.png

Ulrike Protzer

Technische Universität München

c8440fd942e9b2e07a875e3385b35cd3.png

Bali Pulendran

Stanford University School of Medicine

251208c196fed8c8a65dd5f2c7c4b23d.png

Rino Rappuoli

GlaxoSmithKline Vaccines

8f58fa389e8d080b025f78a3a464a2b6.png

Federica Sallusto

Università della Svizzera Italiana & ETH Zurich

c5d01fbe1dee49281341cab6c0271735.png

Robert A. Seder

NIAID, National Institutes of Health

64e2fa15fba3854935c6c9fd839c378e.png

Robin Shattock

Imperial College London

9890182f473f9e51a6853ad8ac0d3e6b.png

Lynda M. Stuart

Bill & Melinda Gates Foundation

b4062116aa67c5f8ed8e6aea03e0682b.png

Christine Shaw

Moderna

Gabriel D. Victora

Gabriel D. Victora

Rockefeller University

e3ad856f1d38de1da1547cdad69d215d.png

Hedda Wardemann

German Cancer Research Center

2a10b0efbed3ce6bb616c4fd6d6eb16c.png

Catherine J. Wu

Dana-Farber Cancer Institute

 
     




Sponsors



custom image
custom image
custom image
custom image
custom image

Funding for this conference was made possible (in part) by 1R13AI150086-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings


custom image
custom image






custom image